The timing of vaccination can be crucial for cancer patients. Ideally, patients should receive the pneumococcal vaccine before starting cancer treatment to ensure they have the best possible immune response. If that’s not feasible, they should be vaccinated during a period of stable health and when their white blood cell counts are at relatively normal levels. Oncologists often work with infectious disease specialists to determine the optimal timing.